Lexicon Pharmaceuticals to Participate in the Jefferies London Global Healthcare Conference
THE WOODLANDS, Texas, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced its participation in the...
Pharmaceutical
Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
CONSHOHOCKEN, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate...
Recce Pharmaceuticals Advances Patient Dosing to Final Stages in Phase II Trial for Acute Bacterial Skin and Skin Structure Infections
Trial reaches dosing milestone, with 20 of the 30 total patients dosedAll patients dosed met the primary endpoints of the...
ARS Pharmaceuticals Announces Conference Call and Webcasts for its Third Quarter 2024 Financial Results and Presentations at Upcoming Conferences
Third Quarter Earnings Conference Call to be Held on November 13 at 8:00 a.m. ETSAN DIEGO, Nov. 06, 2024 (GLOBE...
Pliant Therapeutics to Participate in the Stifel Healthcare Conference
SOUTH SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that Keith Cummings, M.D.,...
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
– Topline data from pivotal Phase 3 TANDEM trial now expected in 4Q 2024 due to faster than expected enrollment...
Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality
NEWTON, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel...
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434
– Peer-Reviewed Publication Describes How ATH434 Uniquely Targets Excess Iron –MELBOURNE, AUSTRALIA and SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE)...
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain...
Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024
Conference call and webcast to begin at 8:00 AM ETBEDFORD, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc....
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Interim analysis for Study 1 of Essential3 Phase 3 program for ulixacaltamide in essential tremor (ET) confirmed for Q1 2025;...
Spago Nanomedical Interim Report January-September 2024
LUND, SWEDEN / ACCESSWIRE / November 6, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Progress for the Tumorad programJULY - SEPTEMBER IN...
Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions
Guidance for 2024 confirmed with full-year 2024 revenue and adjusted EBITDA targets on track, despite challenging market conditionsRobust growth of...
Duoning Biotech announced strategic partnership with Branca Bunús to promote the next generation of transfection reagents
SHANGHAI, Nov. 5, 2024 /PRNewswire/ -- Duoning Biotechnology Group ("Duoning") announced a strategic partnership agreement with Branca Bunús Ltd. ("Branca...
Research Grid raises $6.5 million to make clinical trials admin-free
NEW YORK, Nov. 5, 2024 /PRNewswire/ -- Research Grid, the AI startup that helps medical research institutions automate back-office admin for...
Juva Life Inc. Updates Shareholders on Financial Status and Upcoming Receivership Hearing
REDWOOD CITY, CA / ACCESSWIRE / November 5, 2024 / Juva Life Inc. (CSE:JUVA)(OTC EXPERT MARKET:JUVAF)(FRANKFURT:4VV) ("Juva" or the "Company"),...
Quantiphi, DDReg Partner to Transform Regulatory Reporting in Life Sciences Through AI
MARLBOROUGH, Mass., Nov. 5, 2024 /PRNewswire/ -- Quantiphi, a global AI-first digital engineering company and DDReg, a global leader in...
Particle Counters Market to Hit USD 986.3 Million by 2029 with 9.5% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., Nov. 5, 2024 /PRNewswire/ -- The global particle counters market is estimated to reach USD 986.3 million by...
Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million
NEW YORK, NY / ACCESSWIRE / November 5, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("Protagenic Therapeutics" or the "Company"), a...
Nemysis Limited Announces Completion of Acquisition in Italy
Nemysis Limited is pleased to announce the successful acquisition of TFarma SRL ("TFarma") by its wholly-owned subsidiary, Enteralia Bioscience SRL...